Literature DB >> 14703737

Reversal of aging and chronic ethanol-induced cognitive dysfunction by quercetin a bioflavonoid.

Amanpreet Singh1, Pattipati S Naidu, Shrinivas K Kulkarni.   

Abstract

Cognitive dysfunction, one of the most striking age-related impairments seen in human beings, has been correlated to the vulnerability of the brain to increased oxidative stress during aging process. Quercetin is a bioflavonoid with strong antioxidant properties. Experiments were performed to study the possible effects of quercetin on cognitive performance of young, aged or ethanol-intoxicated mice (an animal model for cognition dysfunction) using one trail step down type of passive avoidance and elevated plus maze tasks, respectively. Aged or chronic ethanol-treated mice showed poor retention of memory in step-down passive avoidance and in elevated plus-maze task. Chronic administration of quercetin (10, 25 and 50 mg/kg) for 30 days or its co-administration with ethanol (15% w/v, 2g/kg per orally) for 24 days significantly reversed the age-related or chronic ethanol-induced retention deficits in both the test paradigms. However, in both memory paradigms chronic administration of quercetin failed to modulate the retention performance of young mice. Chronic quercetin administration for 30 days also reversed age associated increase in TBARS levels and decline in forebrain total glutathione (GSH), SOD and catalase levels. Chronic ethanol administration to young mice produced an increase in lipid peroxidation, and a decline in forebrain total glutathione (GSH), SOD and catalase levels, which was significantly reversed by the co-administration of quercetin (10, 25 and 50 mg/kg). The results of the present study showed that chronic quercetin treatment reverses cognitive deficits in aged and ethanol-intoxicated mice, which is associated with its antioxidant property.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14703737     DOI: 10.1080/10715760310001616014

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  22 in total

1.  Systemic alcohol-protective effects of quercetin besides its ameliorating effect on alcohol-induced neuropathic pain.

Authors:  Shailendra Kapoor
Journal:  Inflammopharmacology       Date:  2012-03-17       Impact factor: 4.473

2.  Effect of chemotherapy exposure prior to pregnancy on fetal brain tissue and the potential protective role of quercetin.

Authors:  Z Doğan; S Kocahan; E Erdemli; E Köse; I Yılmaz; Z Ekincioğlu; N Ekinci; Y Turkoz
Journal:  Cytotechnology       Date:  2014-09-27       Impact factor: 2.058

3.  The protective effect of quercetin on long-term alcohol consumption-induced oxidative stress.

Authors:  Ahmet Kahraman; Hamdullah Çakar; Tülay Köken
Journal:  Mol Biol Rep       Date:  2011-06-15       Impact factor: 2.316

4.  Loss of NRF2 leads to impaired mitochondrial function, decreased synaptic density and exacerbated age-related cognitive deficits.

Authors:  Jonathan A Zweig; Maya Caruso; Mikah S Brandes; Nora E Gray
Journal:  Exp Gerontol       Date:  2019-12-13       Impact factor: 4.032

5.  Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer's disease in rats.

Authors:  Dinesh Kumar Dhull; Ankur Jindal; Rakesh K Dhull; Saurabh Aggarwal; Deepak Bhateja; Satyanarayana S V Padi
Journal:  J Mol Neurosci       Date:  2011-06-24       Impact factor: 3.444

6.  Some aspects of the in vivo neuroprotective capacity of flavonoids: bioavailability and structure-activity relationship.

Authors:  Felicia Rivera; Jessika Urbanavicius; Elena Gervaz; Andrea Morquio; Federico Dajas
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

7.  Quercetin protects against chronic aluminum-induced oxidative stress and ensuing biochemical, cholinergic, and neurobehavioral impairments in rats.

Authors:  Deep Raj Sharma; Willayat Yousuf Wani; Aditya Sunkaria; Ramesh J L Kandimalla; Deepika Verma; Swaranjit Singh Cameotra; Kiran Dip Gill
Journal:  Neurotox Res       Date:  2012-08-24       Impact factor: 3.911

8.  The effects of quercetin supplementation on cognitive functioning in a community sample: a randomized, placebo-controlled trial.

Authors:  Joshua J Broman-Fulks; Will H Canu; Krystal L Trout; David C Nieman
Journal:  Ther Adv Psychopharmacol       Date:  2012-08

9.  Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease.

Authors:  Mubeen Ahmad Ansari; Hafiz Mohammad Abdul; Gururaj Joshi; Wycliffe O Opii; D Allan Butterfield
Journal:  J Nutr Biochem       Date:  2008-07-07       Impact factor: 6.048

Review 10.  Cholinesterase targeting by polyphenols: A therapeutic approach for the treatment of Alzheimer's disease.

Authors:  Nasimudeen R Jabir; Fayaz Rahman Khan; Shams Tabrez
Journal:  CNS Neurosci Ther       Date:  2018-05-16       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.